跳至主要内容
临床试验/CTRI/2024/07/070803
CTRI/2024/07/070803尚未招募2 期

A Randomised Clinical Study To Evaluate The Effect Of Agnikarma With Tamra Shalaka In The Management Of Bahupitta Kamala W.S.R. To Hepato-Cellular Jaundice. - NI

Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients presenting with diagnostic features of Bahupitta Kamala/ Hepato-cellular Jaundice for minimal of 7 days.

排除标准

  • 1.Patients contraindicated for Agnikarma as per texts.
  • 2.Patients with Total bilirubin level more 10mg/dl.
  • 3.Patients with Alkaline phosphate levels greater than double the normal range (i.e more 300 IU)
  • 4.Pregnancy or lactating women.
  • 5.Bleeding disorders.
  • 6.Uncontrolled Diabetes mellitus (HbA1C more 7%)
  • 7.Cardiac diseases [Ischemic heart disease, Coronary heart disease, Myocardial infarction]
  • AIDS, TB, Hepatitis B and Hepatitis C.
  • 8.Obstructive Jaundice
  • 9.Tumors of Hepato-biliary system.
  • 10.Any other symptomatic illness which interferes in treatment.

研究者

发起方
Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital

相似试验